Management of post-transplant lymphoproliferative disorders
Author:
Affiliation:
1. Department of Hematology; MedStar Washington Hospital Center; Washington DC USA
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15263/fullpdf
Reference100 articles.
1. The role of antiviral prophylaxis for the prevention of Epstein-Barr Virus-associated posttransplant lymphoproliferative disease in solid organ transplant recipients: a systematic review;Al Dabbagh;American Journal of Transplantation,2017
2. Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes;Barker;Blood,2010
3. Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma;Barta;Cancer,2012
4. Telomere dynamics in immune senescence and exhaustion triggered by chronic viral infection;Bellon;Viruses,2017
5. Bortezomib and rituximab in the treatment of post-transplant lymphoproliferative disorders;Blaes;Blood,2011
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes;International Journal of Molecular Sciences;2023-11-07
2. Quantitative Viral Load Monitoring;Advances in Molecular Pathology;2023-11
3. 18F-FDG PET/CT findings in a patient with blastic plasmacytoid dendritic cell neoplasm and post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: a case report;Frontiers in Medicine;2023-08-17
4. Non-invasive monitoring associated with B lymphoma cells in post-transplant lymphoproliferative disorder (PTLD) patients: Systematic review;Human Antibodies;2023-05-15
5. Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab;Frontiers in Immunology;2023-03-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3